[Intensive outpatient treatment - a therapy option for all patients in child and adolescent psychiatry or just for a few?]

Autor: Boege I; ZfP Südwürttemberg, Akademisches Lehrkrankenhaus der Universität Ulm, Ravensburg, Deutschland.; KJPP Universität Ulm, Ulm, Deutschland., Schepker R; ZfP Südwürttemberg, Akademisches Lehrkrankenhaus der Universität Ulm, Ravensburg, Deutschland., Grupp D; ZfP Südwürttemberg, Akademisches Lehrkrankenhaus der Universität Ulm, Ravensburg, Deutschland., Fegert JM; KJPP Universität Ulm, Ulm, Deutschland.
Jazyk: němčina
Zdroj: Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie [Z Kinder Jugendpsychiatr Psychother] 2020 Sep; Vol. 48 (5), pp. 348-357. Date of Electronic Publication: 2020 Feb 25.
DOI: 10.1024/1422-4917/a000711
Abstrakt: Intensive outpatient treatment - a therapy option for all patients in child and adolescent psychiatry or just for a few? Abstract. Objective: "Child and adolescent psychiatric ward-equivalent treatment" (= stationsäquivalente Behandlung, StäB) is an intensive daily home treatment that has now become available in Germany. Conditions for StäB services were negotiated were negotiated, authorized and came into force by German healthcare commissioners and hospitals on 1 January 2018. However, to date few hospitals in Germany offer StäB, and its feasibility has been questioned. This study evaluates the first 58 cases of StäB in the Department of Child and Adolescent Psychiatry, ZfP Südwürttemberg (2018-2019). Method: All patients admitted consecutively to StäB from 1 January 2018 to 15 August 2019 were included and evaluated solely using descriptive analyses in SPSS.25. Results: The average length of stay in StäB was 37.95 days (SD 15.35). 86.2 % of the families completed treatment, with 3 patients discontinuing treatment and 5 patients needing inpatient admission. Unlike in the literature, internalising disorders predominated (70.7 %), whereas externalizing disorders were diagnosed in only 27.8 % of the patients. The cost of treatment in StäB was on average 8779.25 €. Conclusions: StäB is a viable and well-accepted new treatment alternative for patients requiring inpatient admission. The multiprofessionality of treatment as well as daily contacts are required. Feasibility under the conditions set is given. The average length of stay is slightly longer, but the costs are lower than those of inpatient treatment.
Databáze: MEDLINE